A 9-Valent HPV Vaccine against Infection and Intraepithelial Neoplasia in Women
New England Journal of Medicine2015Vol. 372(8), pp. 711–723
Citations Over TimeTop 1% of 2015 papers
Elmar A. Joura, Anna R. Giuliano, Ole‐Erik Iversen, Céline Bouchard, Constance Mao, Jesper Mehlsen, Edson Duarte Moreira, Yuen Ngan, Lone Kjeld Petersen, Eduardo Lazcano‐Ponce, Punnee Pitisuttithum, Jaime Alberto Restrepo, Gavin Stuart, Linn Woelber, Yuh Cheng Yang, Jack Cuzick, Suzanne M. Garland, Warner K. Huh, Susanne K. Kjær, Oliver Bautista, Ivan S. F. Chan, Joshua Chen, Richard Gesser, Erin Moeller, Michael Ritter, Scott Vuocolo, Alain Luxembourg
Abstract
The 9vHPV vaccine prevented infection and disease related to HPV-31, 33, 45, 52, and 58 in a susceptible population and generated an antibody response to HPV-6, 11, 16, and 18 that was noninferior to that generated by the qHPV vaccine. The 9vHPV vaccine did not prevent infection and disease related to HPV types beyond the nine types covered by the vaccine. (Funded by Merck; ClinicalTrials.gov number, NCT00543543).
Related Papers
- Susquehanna Chorale Spring Concert "Roots and Wings"(2017)
- → DETERMINING QUALITY REQUIREMENTS AT THE UNIVERSITIES TO IMPROVE THE QUALITY OF EDUCATION(2018)
- → Genentech taps Affimed’s antibodies(2018)
- Enxerto livre de arteria epigastrica inferior: avaliacao hemodinamica e angiografica pre e pos-operatoria(1988)
- → KOMPLIKASI REGIONAL ANESTESI PADA PEDIATRIK(2023)